The Congressional committee investigating Imclone systems requested Thursday that the company's chief executive, Dr. Samuel D. Waksal, provide information regarding any sales of company stock by his relatives or by offshore accounts he controlled.
House panel asks Imclone Ceo to explain stock trades.